Amicus Therapeutics
Price & Volume
Stats
See more52W Range | $5.51-$14.38 |
Market Cap | $4.5B |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $634.2M |
Revenue Growth (YoY) | 23.7% |
Gross Profit (12 Mos) | $561.2M |
Diluted EPS | -$0.04 |
News
See moreYahoo Finance • 6 days ago
Amicus Therapeutics Non-GAAP EPS of $0.31, revenue of $634M
Yahoo Finance • 7 days ago
Halper Sadeh LLC is Investigating Whether RAPT, CTGO, TBN, FOLD are Obtaining Fair Deals for their Shareholders
Yahoo Finance • 10 days ago
BioMarin Debt Deal And VOXZOGO Approval Recast Rare Disease Outlook
Yahoo Finance • 24 days ago
Jefferies Downgrades Amicus Therapeutics, Inc. (FOLD) to Buy And Lowers Price Target Amid Takeover Developments
About
CEO | Mr. Bradley L. Campbell M.B.A. |
Address | 47 Hulfish Street, Princeton, NJ, United States, 08542 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 499 |
